Your browser doesn't support javascript.
loading
Posttransplantation cyclophosphamide expands functional myeloid-derived suppressor cells and indirectly influences Tregs.
Fletcher, Rochelle E; Nunes, Natalia S; Patterson, Michael T; Vinod, Natasha; Khan, Shanzay M; Mendu, Suresh K; Li, Xianghong; de Paula Pohl, Alessandra; Wachsmuth, Lucas P; Choo-Wosoba, Hyoyoung; Eckhaus, Michael A; Venzon, David J; Kanakry, Christopher G.
  • Fletcher RE; Center for Immuno-Oncology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD.
  • Nunes NS; Center for Immuno-Oncology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD.
  • Patterson MT; Center for Immuno-Oncology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD.
  • Vinod N; Center for Immuno-Oncology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD.
  • Khan SM; Center for Immuno-Oncology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD.
  • Mendu SK; Center for Immuno-Oncology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD.
  • Li X; Center for Immuno-Oncology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD.
  • de Paula Pohl A; Center for Immuno-Oncology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD.
  • Wachsmuth LP; Center for Immuno-Oncology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD.
  • Choo-Wosoba H; Biostatistics and Data Management Section, Office of the Clinical Director, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD.
  • Eckhaus MA; Division of Veterinary Resources, Office of Research Services, Office of the Director, National Institutes of Health, Bethesda, MD.
  • Venzon DJ; Biostatistics and Data Management Section, Office of the Clinical Director, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD.
  • Kanakry CG; Center for Immuno-Oncology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD.
Blood Adv ; 7(7): 1117-1129, 2023 04 11.
Article en En | MEDLINE | ID: mdl-36595377

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Trasplante de Células Madre Hematopoyéticas / Células Supresoras de Origen Mieloide / Enfermedad Injerto contra Huésped Tipo de estudio: Prognostic_studies Límite: Animals Idioma: En Año: 2023 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Trasplante de Células Madre Hematopoyéticas / Células Supresoras de Origen Mieloide / Enfermedad Injerto contra Huésped Tipo de estudio: Prognostic_studies Límite: Animals Idioma: En Año: 2023 Tipo del documento: Article